| RS1820531050 |
CDKN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial melanoma, Neoplasm |
| RS1820538211 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Melanoma-pancreatic cancer syndrome |
| RS1820538394 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS1820557069 |
SMARCA2
|
Health Risk |
Likely pathogenic |
Blepharophimosis - intellectual disability syndrome, Blepharophimosis - intellectual disability syndrome |
| RS1820558146 |
SMARCA2
|
Health Risk |
Likely pathogenic |
Nicolaides-Baraitser syndrome, SMARCA2-related disorder |
| RS182064161 |
SLC5A5
|
Health Risk |
Conflicting classifications of pathogenicity |
Thyroid dyshormonogenesis 1, Thyroid dyshormonogenesis 1 |
| RS182072601 |
WHRN
|
Health Risk |
Conflicting classifications of pathogenicity |
WHRN-related disorder, WHRN-related disorder |
| RS182074603 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Heterotopia, periventricular |
| RS182076681 |
FBXL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial DNA depletion syndrome 13, Mitochondrial DNA depletion syndrome 13 |
| RS182078347 |
PCLO
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Pontocerebellar hypoplasia type 3 |
| RS182078921 |
CFI
|
Health Risk |
Conflicting classifications of pathogenicity |
CFI-related disorder, Age related macular degeneration 13 |
| RS182079744 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS1820823886 |
TG
|
Health Risk |
Pathogenic |
— |
| RS1820836522 |
SIGMAR1
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis type 16, Amyotrophic lateral sclerosis type 16 |
| RS182084936 |
PRKAG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal congenital glycogen storage disease of heart, Cardiomyopathy |
| RS182086301 |
TET3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS182086857 |
CDC6
|
Health Risk |
Conflicting classifications of pathogenicity |
Meier-Gorlin syndrome 5, Meier-Gorlin syndrome 5 |
| RS182092782 |
CIT
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1820936580 |
SIGMAR1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Amyotrophic lateral sclerosis type 16 |
| RS182094106 |
DNAJC21
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial pancreatic carcinoma, Lung cancer |
| RS182094691 |
SPTBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS182096110 |
PROM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Cone-rod dystrophy 12 |
| RS182096636 |
DARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome, Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome |
| RS182097151 |
HADH
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of 3-hydroxyacyl-CoA dehydrogenase, Hyperinsulinemic hypoglycemia |
| RS182100655 |
ANKRD26
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS182102510 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS182103023 |
ADAMTS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, dermatosparaxis type |
| RS1821068883 |
TOPORS
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1821069325 |
TOPORS
|
Health Risk |
Likely pathogenic |
— |
| RS1821069769 |
TOPORS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1821070611 |
TOPORS
|
Health Risk |
Likely pathogenic |
— |
| RS1821111380 |
GALT
|
Health Risk |
Pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS1821141007 |
GALT
|
Health Risk |
Pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS1821147877 |
GALT
|
Health Risk |
Likely pathogenic |
Galactosemia, Galactosemia |
| RS1821157539 |
GALT
|
Health Risk |
Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS1821163303 |
GALT
|
Health Risk |
Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS182116576 |
RPS6KC1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1821166689 |
CPSF1
|
Health Risk |
Likely pathogenic |
Myopia 27, Myopia 27 |
| RS1821166869 |
GALT
|
Health Risk |
Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS1821175162 |
GALT
|
Health Risk |
Likely pathogenic |
Galactosemia, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS1821176206 |
GALT
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS1821178833 |
GALT
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS1821183505 |
GALT
|
Health Risk |
Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS1821187430 |
GALT
|
Health Risk |
Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS1821187550 |
GALT
|
Health Risk |
Pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS1821198172 |
GALT
|
Health Risk |
Pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS1821203474 |
GALT
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Galactosemia |
| RS182120395 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex 5B, with muscular dystrophy |
| RS182123615 |
JAK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Acquired polycythemia vera, 6 conditions |
| RS182125538 |
LOXHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 77, LOXHD1-related disorder |
| RS182127067 |
POU1F1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS182127619 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS1821315647 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1821322134 |
IL11RA
|
Health Risk |
Likely pathogenic |
IL11RA-related disorder, IL11RA-related disorder |
| RS1821344202 |
CSPP1
|
Health Risk |
Pathogenic |
Joubert syndrome 21, Joubert syndrome 21 |
| RS1821349181 |
IL11RA
|
Health Risk |
Likely pathogenic |
IL11RA-related disorder, IL11RA-related disorder |
| RS182135982 |
NPHP3
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephronophthisis, Nephronophthisis 3 |
| RS182139018 |
DIAPH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 1, Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome |
| RS182139048 |
FBXL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial DNA depletion syndrome 13, Mitochondrial DNA depletion syndrome 13 |
| RS1821395350 |
TG
|
Health Risk |
Pathogenic |
— |
| RS182143561 |
CHIT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Chitotriosidase deficiency, Chitotriosidase deficiency |
| RS182144074 |
ETFDH
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple acyl-CoA dehydrogenase deficiency, Inborn genetic diseases |
| RS182144885 |
WDPCP
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Inborn genetic diseases |
| RS1821460043 |
DNAAF11
|
Health Risk |
Likely pathogenic |
DNAAF11-related disorder, DNAAF11-related disorder |
| RS1821475039 |
DNAAF11
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 19 |
| RS182151153 |
EYS
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinal dystrophy |
| RS1821577573 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1821581008 |
SMARCA2
|
Health Risk |
Likely pathogenic |
Nicolaides-Baraitser syndrome, SMARCA2-related BAFopathy |
| RS1821584135 |
SMARCA2
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS182159084 |
SYNE4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1821604564 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS182161195 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Tibial muscular dystrophy, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS182161386 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1821629207 |
KAT6A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome, Inborn genetic diseases |
| RS182164052 |
MATN3
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple epiphyseal dysplasia type 5, Multiple epiphyseal dysplasia type 5 |
| RS1821653681 |
SMARCA2
|
Health Risk |
Pathogenic |
Nicolaides-Baraitser syndrome, Nicolaides-Baraitser syndrome |
| RS1821654702 |
CNGB3
|
Health Risk |
Pathogenic/Likely pathogenic |
Achromatopsia 3, Achromatopsia 3 |
| RS1821661078 |
KAT6A
|
Health Risk |
Pathogenic |
Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome, Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome |
| RS1821663767 |
KAT6A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome, Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome |
| RS1821677152 |
KAT6A
|
Health Risk |
Likely pathogenic |
Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome, Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome |
| RS1821677301 |
KAT6A
|
Health Risk |
Likely pathogenic |
Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome, Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome |
| RS1821713775 |
CNGB3
|
Health Risk |
Likely pathogenic |
Achromatopsia 3, Achromatopsia 3 |
| RS1821721248 |
KAT6A
|
Health Risk |
Likely pathogenic |
Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome, Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome |
| RS1821721453 |
KAT6A
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS1821749145 |
KAT6A
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS1821750171 |
KAT6A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1821770366 |
KAT6A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1821779826 |
RUSC2
|
Health Risk |
Likely pathogenic |
— |
| RS182184747 |
SZT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 18 |
| RS182185801 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS182189497 |
XPC
|
Health Risk |
Conflicting classifications of pathogenicity |
Xeroderma pigmentosum, group C |
| RS1821898026 |
KAT6A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1821915703 |
KAT6A
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Glioma susceptibility 1 |
| RS182194007 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1821971485 |
SLC39A4
|
Health Risk |
Likely pathogenic |
— |
| RS1822010348 |
RUSC2
|
Health Risk |
Pathogenic |
— |
| RS1822017858 |
SLC39A4
|
Health Risk |
Pathogenic |
— |
| RS182202446 |
TNRC18
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1822038329 |
SLC39A4
|
Health Risk |
Pathogenic |
— |
| RS1822061222 |
SLC39A4
|
Health Risk |
Likely pathogenic |
— |